Change, Growth, and Successes
The past 12 months have been one of change, growth and successes for the American Association of Homeopathic Pharmacists. These continued the positive achievements of the association during the 90th…
Read MoreAssays of homeopathic preparations
An interesting contribution, Quality Aspects Of Homoeopathic Preparations, appeared in Pharmeuropa Online, a publication of the European Directorate for the Quality of Medicines and HealthCare (EDQM). In his paper, Professor…
Read MoreAssays of Homeopathic Preparations
AAHP calls attention to an article contending that, because homeopathic preparations are not governed by conventional dose-response relationships, assays and analytical markers often cannot be linked to the efficacy of the finished product. …
Read More2014 Elections and Effect on Homeopathic Industry
This Month’s Election and the Homeopathic Industry by Pete Evich of van Scoyoc Associates This overview provides a succinct discussion of how the November 4th U.S. Congressional elections may affect…
Read MoreRecall Trends 2Qtr 2014
Each quarter, Stericycle produces a summary report of recalls affecting several industries, including the overall Pharma category. With snapshot graphics, the report notes that Pharma recalls are inching steadily upwards.…
Read MoreTwo Informative FDA Guidance documents
FDA has issued a Guidance for Industry document, ANDA Submissions ― Refuse-to-Receive Standards, which contains helpful hints on the Agency’s thinking and practices. Much of the contents may not be…
Read MoreSept ’14 Member Meeting Successes
The AAHP’s Semi-Annual Member Meeting in Baltimore was an unparalleled success with two new highlights capping the event. After an opening welcome by AAHP President Mark Land, the meeting began…
Read MoreAAHP Semi-Annual Meeting
The AAHP’s Semi-Annual Meeting will be held Friday, September 19 in Baltimore, MD at 9am. We will meet in the Holiday Inn, Inner Harbor at 301 West Lombard Street, just…
Read MoreSocial Media and Products Subject to FDA Regulation
by Eric L. Foxman The use of the internet and social media promotion has complicated the previously simple review of FDA regulated industries by the Agency. In response, FDA has…
Read MoreFDA & Proprietary Names
FDA has published a draft document on “Best Practices in Developing Proprietary Names for Drugs”. This document is intended to help companies develop product names that do not cause or…
Read More